Knoll Skin Shine Cream is a topical formulation containing Hydroquinone (2% w/w), Mometasone Furoate (0.1% w/w), and Tretinoin (0.025% w/w), designed for the treatment of hyperpigmentation disorders such as melasma, post-inflammatory hyperpigmentation, and other pigmentary abnormalities. Hydroquinone acts as a depigmenting agent by inhibiting tyrosinase, thereby reducing melanin synthesis and promoting skin lightening. Mometasone Furoate, a potent corticosteroid, provides anti-inflammatory and immunosuppressive effects, helping to reduce erythema, swelling, and irritation associated with pigmentary conditions. Tretinoin, a retinoid, facilitates increased epidermal turnover and enhances the penetration of hydroquinone, promoting the removal of pigmented keratinocytes and improving skin texture. The combination of these active ingredients offers a synergistic effect for effective management of resistant hyperpigmentation. Knoll Skin Shine Cream should be applied once daily to the affected area, preferably at night, under medical supervision. Caution is advised due to potential side effects such as skin irritation, dryness, erythema, and increased photosensitivity. Patients are recommended to use sunscreen during the day to prevent further pigmentation. This product is contraindicated in individuals with hypersensitivity to any component and should be avoided during pregnancy and lactation unless deemed necessary by a healthcare professional.